Albireo Pharma Inc.
ALBO
NSC
Sector: Healthcare
Industry: Biotechnology
26.37
USD
2.80
(11.88%)
Optionable: Yes Market Cap: 384 M 90-day average vol: 0
Previous close: 23.57 Open: 23.31 Bid: 27.0 Ask: 27.0
52 week range
0.00 0.00
Last updated: Monday 8th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Albireo Pharma (ALBO) Reports Q4 Loss, Tops Revenue Estimates
Yahoo Finance 3/1/2022
Albireo Pharma GAAP EPS of -$0.57, revenue of $32.52M
Seeking Alpha 3/1/2022
Albireo Reports Q4 and Year-End 2021 Financial Results and Business Update
Yahoo Finance 3/1/2022
Albireo Pharma Q4 2021 Earnings Preview
Seeking Alpha 2/28/2022
Is a Surprise Coming for Albireo Pharma (ALBO) This Earnings Season?
Yahoo Finance 2/28/2022
Noema Pharma Appoints Michael Gutch as Chief Financial Officer
Yahoo Finance 2/28/2022
Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates
Yahoo Finance 2/24/2022
The Zacks Analyst Blog Highlights Teladoc Health, Albireo Pharma and The Joint Corp
Yahoo Finance 2/22/2022
Albireo to Report Q4 and Year-End 2021 Financial Results on March 1
Yahoo Finance 2/22/2022
NICE Recommends Albireo’s Bylvay® (odevixibat) for All PFIC Types
Yahoo Finance 2/22/2022
Albireo Pharma (ALBO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Yahoo Finance 2/17/2022
Albireo Announces Publication of the PICTURE Study Highlighting the Caregiver Impact of PFIC, a Rare and Devastating Children’s Liver Disease
Yahoo Finance 2/14/2022
10 Biotech Stocks to Buy According to Matthew Strobeck’s Birchview Capital
Yahoo Finance 2/3/2022
Adult Liver Diseases: The R&D Engine Drives Albireo's Long-Term Prospects
Seeking Alpha 2/1/2022
Albireo: Successful And Accelerating Global Launch Drives Sales Revenue
Seeking Alpha 1/31/2022
When Can We Expect A Profit From Albireo Pharma, Inc. (NASDAQ:ALBO)?
Yahoo Finance 1/19/2022
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!